Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123896134 | 12389613 | 4 | F | 2016 | 20160815 | 20160520 | 20160817 | EXP | US-PFIZER INC-2016266083 | PFIZER | 67.00 | YR | F | Y | 61.23000 | KG | 20160817 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123896134 | 12389613 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 225 MG (150 MG PLUS 75 MG), 1X/DAY | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 123896134 | 12389613 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, 1X/DAY(EVERY MORNING) | 0 | 5 | MG | QD | ||||||||
| 123896134 | 12389613 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, 1X/DAY(AT BEDTIME) | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123896134 | 12389613 | 1 | Depression |
| 123896134 | 12389613 | 2 | Hypertension |
| 123896134 | 12389613 | 3 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123896134 | 12389613 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123896134 | 12389613 | Incontinence | |
| 123896134 | 12389613 | Nephrolithiasis | |
| 123896134 | 12389613 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123896134 | 12389613 | 1 | 2008 | 0 | ||
| 123896134 | 12389613 | 2 | 2011 | 0 | ||
| 123896134 | 12389613 | 3 | 2011 | 0 |